Corneal epithelial stem cells and their therapeutic application

Trends in Stem Cell Biology and Technology

Volumn , Issue , 2009, Pages 319-365

  Kolli, Sai ^a   Lako, Majlinda ^a   Figueiredo, Francisco ^a   Ahmad, Sajjad ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Allograft; Amniotic membrane; Autograft; Corneal epithelial stem cell; Corneal epithelium; Cultured limbal stem cells; Limbal stem cell; Limbal stem cell deficiency; Stem cell; Stem cell transplantation

Indexed keywords

EID: 80052989913     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-60327-905-5_18     Document Type: Chapter

References (256)

1. Whitcher JP, Srinivasan M, Upadhyay MP. Corneal blindness: a global perspective. Bull World Health Organ 2001; 79: 214-21 .
2. Boulton M, Albon J. Stem cells in the eye. Int J Biochem Cell Biol 2004; 36: 643-57 .
3. Stepp MA, Zieske JD. The corneal epithelial stem cell niche. Ocul Surf 2005; 3: 15-26 .
4. Dua HS, Azuara-Blanco A. Limbal stem cells of the corneal epithelium. Surv Ophthalmol 2000; 44: 415-25 .
5. Tseng SC. Concept and application of limbal stem cells. Eye 1989; 3 (Pt 2): 141-57 .
6. Schermer A, Galvin S, Sun TT. Differentiation-related expression of a major 64K corneal keratin in vivo and in culture suggests limbal location of corneal epithelial stem cells. J Cell Biol 1986; 103: 49-62 .
7. Potten CS, Hume WJ, Reid P, Cairns J. The segregation of DNA in epithelial stem cells. Cell 1978; 15: 899-906 .
8. Zieske JD. Perpetuation of stem cells in the eye. Eye 1994; 8 (Pt 2): 163-9 .
9. Schofield R. The stem cell system. Biomed Pharmacother 1983; 37: 375-80 .
10. Thoft RA, Friend J. The X, Y, Z hypothesis of corneal epithelial maintenance. Invest Ophthalmol Vis Sci 1983; 24: 1442-3 .
11. Lavker RM, Dong G, Cheng SZ, Kudoh K, Cotsarelis G, Sun TT. Relative proliferative rates of limbal and corneal epithelia. Implications of corneal epithelial migration, circadian rhythm, and suprabasally located DNA-synthesizing keratinocytes. Invest Ophthalmol Vis Sci 1991; 32: 1864-75 .
12. Chen JJ, Tseng SC. Abnormal corneal epithelial wound healing in partial-Thickness removal of limbal epithelium. Invest Ophthalmol Vis Sci 1991; 32: 2219-33 .
13. Davanger M, Evensen A. Role of the pericorneal papillary structure in renewal of corneal epithelium. Nature 1971; 229: 560-1 .
14. Kurpakus MA, Stock EL, Jones JC. Expression of the 55-kD/64-kD corneal keratins in ocular surface epithelium. Invest Ophthalmol Vis Sci 1990; 31: 448-56 .
15. Bickenbach JR. Identification and behavior of label-retaining cells in oral mucosa and skin. J Dent Res 1981; 60 (Spec No C): 1611-20 .
16. Cotsarelis G, Cheng SZ, Dong G, Sun TT, Lavker RM. Existence of slow-cycling limbal epithelial basal cells that can be preferentially stimulated to proliferate: implications on epithelial stem cells. Cell 1989; 57: 201-9 .
17. Ebato B, Friend J, Thoft RA. Comparison of limbal and peripheral human corneal epithelium in tissue culture. Invest Ophthalmol Vis Sci 1988; 29: 1533-7 .
18. Hanna C, OBrien JE. Cell production and migration in the epithelial layer of the cornea. Arch Ophthalmol 1960; 64: 536-9 .
19. Chen JJ, Tseng SC. Corneal epithelial wound healing in partial limbal deficiency. Invest Ophthalmol Vis Sci 1990; 31: 1301-14 .
20. Huang AJ, Tseng SC. Corneal epithelial wound healing in the absence of limbal epithelium. Invest Ophthalmol Vis Sci 1991; 32: 96-105 .
21. Matsuda M, Ubels JL, Edelhauser HF. A larger corneal epithelial wound closes at a faster rate. Invest Ophthalmol Vis Sci 1985; 26: 897-900 .
22. Srinivasan BD, Eakins KE. The reepithelialization of rabbit cornea following single and multiple denudation. Exp Eye Res 1979; 29: 595-600.
23. Kenyon KR, Tseng SC. Limbal autograft transplantation for ocular surface disorders. Ophthalmology 1989; 96: 709-22; discussion 22-3 .
24. Tsai RJ, Sun TT, Tseng SC. Comparison of limbal and conjunctival autograft transplantation in corneal surface reconstruction in rabbits. Ophthalmology 1990; 97: 446-55 .
25. Waring GO 3rd, Roth AM, Ekins MB. Clinical and pathologic description of 17 cases of corneal intraepithelial neoplasia. Am J Ophthalmol 1984; 97: 547-59 .
26. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature 2001; 414: 105-11 .
27. Potten CS, Loeffler M. Stem cells: attributes, cycles, spirals, pitfalls and uncertainties. Lessons for and from the crypt. Development 1990; 110: 1001-20 .
28. Lehrer MS, Sun TT, Lavker RM. Strategies of epithelial repair: modulation of stem cell and transit amplifying cell proliferation. J Cell Sci 1998; 111 (Pt 19): 2867-75 .
29. Hanna C, Bicknell DS, OBrien JE. Cell turnover in the adult human eye. Arch Ophthalmol 1961; 65: 695-8 .
30. Townsend WM. The limbal palisades of Vogt. Trans Am Ophthalmol Soc 1991; 89: 721-56 .
31. Gipson IK. The epithelial basement membrane zone of the limbus. Eye 1989; 3 (Pt 2): 132-40 .
32. Wiley L, SundarRaj N, Sun TT, Thoft RA. Regional heterogeneity in human corneal and limbal epithelia: an immunohistochemical evaluation. Invest Ophthalmol Vis Sci 1991; 32: 594-602 .
33. Ljubimov AV, Burgeson RE, Butkowski RJ, Michael AF, Sun TT, Kenney MC. Human corneal basement membrane heterogeneity: topographical differences in the expression of type IV collagen and laminin isoforms. Lab Invest 1995; 72: 461-73 .
34. Chen Z, de Paiva CS, Luo L, Kretzer FL, Pflugfelder SC, Li DQ. Characterization of putative stem cell phenotype in human limbal epithelia. Stem Cells 2004; 22: 355-66 .
35. Espana EM, Di Pascuale M, Grueterich M, Solomon A, Tseng SC. Keratolimbal allograft in corneal reconstruction. Eye 2004; 18: 406-17 .
36. Kasper M, Moll R, Stosiek P, Karsten U. Patterns of cytokeratin and vimentin expression in the human eye. Histochemistry 1988; 89: 369-77 .
37. Kasper M. Patterns of cytokeratins and vimentin in guinea pig and mouse eye tissue: evidence for regional variations in intermediate filament expression in limbal epithelium. Acta Histochem 1992; 93: 319-32 .
38. Schlotzer-Schrehardt U, Kruse FE. Identification and characterization of limbal stem cells. Exp Eye Res 2005; 81: 247-64 .
39. Hayashi K, Kenyon KR. Increased cytochrome oxidase activity in alkali-burned corneas. Curr Eye Res 1988; 7: 131-8 .
40. Steuhl KP, Thiel HJ. Histochemical and morphological study of the regenerating corneal epithelium after limbus-To-limbus denudation. Graefes Arch Clin Exp Ophthalmol 1987; 225: 53-8 .
41. Zieske JD, Bukusoglu G, Yankauckas MA. Characterization of a potential marker of corneal epithelial stem cells. Invest Ophthalmol Vis Sci 1992; 33: 143-52 .
42. Zieske JD, Bukusoglu G, Yankauckas MA, Wasson ME, Keutmann HT. Alpha-enolase is restricted to basal cells of stratified squamous epithelium. Dev Biol 1992; 151: 18-26 .
43. Chung EH, DeGregorio PG, Wasson M, Zieske JD. Epithelial regeneration after limbus-Tolimbus debridement. Expression of alpha-enolase in stem and transient amplifying cells. Invest Ophthalmol Vis Sci 1995; 36: 1336-43 .
44. Tseng SC, Li DQ. Comparison of protein kinase C subtype expression between normal and aniridic human ocular surfaces: implications for limbal stem cell dysfunction in aniridia. Cornea 1996; 15: 168-78 .
45. Joyce NC, Meklir B, Joyce SJ, Zieske JD. Cell cycle protein expression and proliferative status in human corneal cells. Invest Ophthalmol Vis Sci 1996; 37: 645-55 .
46. Chen Z, Evans WH, Pflugfelder SC, Li DQ. Gap junction protein connexin 43 serves as a negative marker for a stem cell-containing population of human limbal epithelial cells. Stem Cells 2006; 24: 1265-73.
47. Pellegrini G, Dellambra E, Golisano O, et al. p63 identifies keratinocyte stem cells. Proc Natl Acad Sci U S A 2001; 98: 3156-61 .
48. Di Iorio E, Barbaro V, Ruzza A, Ponzin D, Pellegrini G, De Luca M. Isoforms of DeltaNp63 and the migration of ocular limbal cells in human corneal regeneration. Proc Natl Acad Sci U S A 2005; 102: 9523-8 .
49. Di Iorio E, Barbaro V, Ferrari S, Ortolani C, De Luca M, Pellegrini G. Q-FIHC: quantification of fluorescence immunohistochemistry to analyse p63 isoforms and cell cycle phases in human limbal stem cells. Microsc Res Tech 2006; 69: 983-91 .
50. Arpitha P, Prajna NV, Srinivasan M, Muthukkaruppan V. High expression of p63 combined with a large N/C ratio defines a subset of human limbal epithelial cells: implications on epithelial stem cells. Invest Ophthalmol Vis Sci 2005; 46: 3631-6 .
51. Barbaro V, Testa A, Di Iorio E, Mavilio F, Pellegrini G, De Luca M. C/EBPdelta regulates cell cycle and self-renewal of human limbal stem cells. J Cell Biol 2007; 177: 1037-49 .
52. Matic M, Petrov IN, Chen S, Wang C, Dimitrijevich SD, Wolosin JM. Stem cells of the corneal epithelium lack connexins and metabolite transfer capacity. Differentiation 1997; 61: 251-60 .
53. Dong Y, Roos M, Gruijters T, et al. Differential expression of two gap junction proteins in corneal epithelium. Eur J Cell Biol 1994; 64: 95-100 .
54. Stepp MA, Zhu L, Sheppard D, Cranfill RL. Localized distribution of alpha 9 integrin in the cornea and changes in expression during corneal epithelial cell differentiation. J Histochem Cytochem 1995; 43: 353-62 .
55. Stepp MA, Zhu L. Upregulation of alpha 9 integrin and tenascin during epithelial regeneration after debridement in the cornea. J Histochem Cytochem 1997; 45: 189-201 .
56. Pajoohesh-Ganji A, Ghosh SP, Stepp MA. Regional distribution of alpha9beta1 integrin within the limbus of the mouse ocular surface. Dev Dyn 2004; 230: 518-28 .
57. Grueterich M, Espana EM, Tseng SC. Ex vivo expansion of limbal epithelial stem cells: amniotic membrane serving as a stem cell niche. Surv Ophthalmol 2003; 48: 631-46 .
58. Lambiase A, Bonini S, Micera A, Rama P, Bonini S, Aloe L. Expression of nerve growth factor receptors on the ocular surface in healthy subjects and during manifestation of inflammatory diseases. Invest Ophthalmol Vis Sci 1998; 39: 1272-5 .
59. Touhami A, Grueterich M, Tseng SC. The role of NGF signaling in human limbal epithelium expanded by amniotic membrane culture. Invest Ophthalmol Vis Sci 2002; 43: 987-94 .
60. de Paiva CS, Chen Z, Corrales RM, Pflugfelder SC, Li DQ. ABCG2 transporter identifies a population of clonogenic human limbal epithelial cells. Stem Cells 2005; 23: 63-73 .
61. Watanabe K, Nishida K, Yamato M, et al. Human limbal epithelium contains side population cells expressing the ATP-binding cassette transporter ABCG2. FEBS Lett 2004; 565: 6-10 .
62. Budak MT, Alpdogan OS, Zhou M, Lavker RM, Akinci MA, Wolosin JM. Ocular surface epithelia contain ABCG2-dependent side population cells exhibiting features associated with stem cells. J Cell Sci 2005; 118: 1715-24 .
63. Chee KY, Kicic A, Wiffen SJ. Limbal stem cells: the search for a marker. Clin Experiment Ophthalmol 2006; 34: 64-73 .
64. Vascotto SG, Griffith M. Localization of candidate stem and progenitor cell markers within the human cornea, limbus, and bulbar conjunctiva in vivo and in cell culture. Anat Rec A Discov Mol Cell Evol Biol 2006; 288: 921-31 .
65. Lohrum MA, Vousden KH. Regulation and function of the p53-related proteins: same family, different rules. Trends Cell Biol 2000; 10: 197-202 .
66. Yang A, Schweitzer R, Sun D, et al. p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature 1999; 398: 714-8 .
67. Celli J, Duijf P, Hamel BC, et al. Heterozygous germline mutations in the p53 homolog p63 are the cause of EEC syndrome. Cell 1999; 99: 143-53 .
68. Yang A, Kaghad M, Wang Y, et al. p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol Cell 1998; 2: 305-16 .
69. Hernandez Galindo EE, Theiss C, Steuhl KP, Meller D. Expression of delta Np63 in response to phorbol ester in human limbal epithelial cells expanded on intact human amniotic membrane. Invest Ophthalmol Vis Sci 2003; 44: 2959-65.
70. Goodell MA, McKinney-Freeman S, Camargo FD. Isolation and characterization of side population cells. Methods Mol Biol 2005; 290: 343-52 .
71. Zhou S, Schuetz JD, Bunting KD, et al. The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat Med 2001; 7: 1028-34 .
72. Lekstrom-Himes J, Xanthopoulos KG. Biological role of the CCAAT/enhancer-binding protein family of transcription factors. J Biol Chem 1998; 273: 28545-8 .
73. ORourke JP, Newbound GC, Hutt JA, DeWille J. CCAAT/enhancer-binding protein delta regulates mammary epithelial cell G0 growth arrest and apoptosis. J Biol Chem 1999; 274: 16582-9 .
74. Molofsky AV, He S, Bydon M, Morrison SJ, Pardal R. Bmi-1 promotes neural stem cell selfrenewal and neural development but not mouse growth and survival by repressing the p16Ink4a and p19Arf senescence pathways. Genes Dev 2005; 19: 1432-7 .
75. Lessard J, Sauvageau G. Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature 2003; 423: 255-60 .
76. Watt FM, Green H. Involucrin synthesis is correlated with cell size in human epidermal cultures. J Cell Biol 1981; 90: 738-42 .
77. Kim HS, Jun Song X, de Paiva CS, Chen Z, Pflugfelder SC, Li DQ. Phenotypic characterization of human corneal epithelial cells expanded ex vivo from limbal explant and single cell cultures. Exp Eye Res 2004; 79: 41-9 .
78. Beyer EC, Paul DL, Goodenough DA. Connexin family of gap junction proteins. J Membr Biol 1990; 116: 187-94 .
79. Chang CC, Trosko JE, el-Fouly MH, Gibson-DAmbrosio RE, DAmbrosio SM. Contact insensitivity of a subpopulation of normal human fetal kidney epithelial cells and of human carcinoma cell lines. Cancer Res 1987; 47: 1634-45 .
80. Wolosin JM, Xiong X, Schutte M, Stegman Z, Tieng A. Stem cells and differentiation stages in the limbo-corneal epithelium. Prog Retin Eye Res 2000; 19: 223-55 .
81. Lee P, Wang CC, Adamis AP. Ocular neovascularization: an epidemiologic review. Surv Ophthalmol 1998; 43: 245-69 .
82. Ambati BK, Nozaki M, Singh N, et al. Corneal avascularity is due to soluble VEGF receptor-1. Nature 2006; 443: 993-7 .
83. Egbert PR, Lauber S, Maurice DM. A simple conjunctival biopsy. Am J Ophthalmol 1977; 84: 798-801 .
84. Nelson JD. Impression cytology. Cornea 1988; 7: 71-81 .
85. Sacchetti M, Lambiase A, Cortes M, Sgrulletta R, Bonini S, Merlo D. Clinical and cytological findings in limbal stem cell deficiency. Graefes Arch Clin Exp Ophthalmol 2005; 243: 870-6 .
86. Donisi PM, Rama P, Fasolo A, Ponzin D. Analysis of limbal stem cell deficiency by corneal impression cytology. Cornea 2003; 22: 533-8 .
87. Elder MJ, Hiscott P, Dart JK. Intermediate filament expression by normal and diseased human corneal epithelium. Hum Pathol 1997; 28: 1348-54 .
88. Kinoshita S, Adachi W, Sotozono C, et al. Characteristics of the human ocular surface epithelium. Prog Retin Eye Res 2001; 20: 639-73 .
89. Cavanagh HD, Petroll WM, Alizadeh H, He YG, McCulley JP, Jester JV. Clinical and diagnostic use of in vivo confocal microscopy in patients with corneal disease. Ophthalmology 1993; 100: 1444-54 .
90. Kobayashi A, Sugiyama K. In vivo confocal microscopy in a patient with keratopigmentation (corneal tattooing). Cornea 2005; 24: 238-40 .
91. Patel DV, Sherwin T, McGhee CN. Laser scanning in vivo confocal microscopy of the normal human corneoscleral limbus. Invest Ophthalmol Vis Sci 2006; 47: 2823-7 .
92. Dua HS. The conjunctiva in corneal epithelial wound healing. Br J Ophthalmol 1998; 82: 1407-11 .
93. Wilson SE, Liang Q, Kim WJ. Lacrimal gland HGF, KGF, and EGF mRNA levels increase after corneal epithelial wounding. Invest Ophthalmol Vis Sci 1999; 40: 2185-90 .
94. Tsubota K, Goto E, Shimmura S, Shimazaki J. Treatment of persistent corneal epithelial defect by autologous serum application. Ophthalmology 1999; 106: 1984-9.
95. Geerling G, Maclennan S, Hartwig D. Autologous serum eye drops for ocular surface disorders. Br J Ophthalmol 2004; 88: 1467-74 .
96. Tsubota K, Goto E, Fujita H, et al. Treatment of dry eye by autologous serum application in Sjogrens syndrome. Br J Ophthalmol 1999; 83: 390-5 .
97. del Castillo JM, de la Casa JM, Sardina RC, et al. Treatment of recurrent corneal erosions using autologous serum. Cornea 2002; 21: 781-3 .
98. Goto E, Shimmura S, Shimazaki J, Tsubota K. Treatment of superior limbic keratoconjunctivitis by application of autologous serum. Cornea 2001; 20: 807-10 .
99. Tsubota K, Satake Y, Ohyama M, et al. Surgical reconstruction of the ocular surface in advanced ocular cicatricial pemphigoid and Stevens-Johnson syndrome. Am J Ophthalmol 1996; 122: 38-52 .
100. Liu L, Hartwig D, Harloff S, Herminghaus P, Wedel T, Geerling G. An optimised protocol for the production of autologous serum eyedrops. Graefes Arch Clin Exp Ophthalmol 2005; 243: 706-14 .
101. Dua HS, Gomes JA, Singh A. Corneal epithelial wound healing. Br J Ophthalmol 1994; 78: 401-8 .
102. Tseng SC, Prabhasawat P, Barton K, Gray T, Meller D. Amniotic membrane transplantation with or without limbal allografts for corneal surface reconstruction in patients with limbal stem cell deficiency. Arch Ophthalmol 1998; 116: 431-41 .
103. Lee SH, Tseng SC. Amniotic membrane transplantation for persistent epithelial defects with ulceration. Am J Ophthalmol 1997; 123: 303-12 .
104. Kruse FE, Joussen AM, Rohrschneider K, et al. Cryopreserved human amniotic membrane for ocular surface reconstruction. Graefes Arch Clin Exp Ophthalmol 2000; 238: 68-75 .
105. Koizumi N, Inatomi T, Quantock AJ, Fullwood NJ, Dota A, Kinoshita S. Amniotic membrane as a substrate for cultivating limbal corneal epithelial cells for autologous transplantation in rabbits. Cornea 2000; 19: 65-71 .
106. Choi TH, Tseng SC. In vivo and in vitro demonstration of epithelial cell-induced myofibroblast differentiation of keratocytes and an inhibitory effect by amniotic membrane. Cornea 2001; 20: 197-204 .
107. Kim JS, Kim JC, Na BK, Jeong JM, Song CY. Amniotic membrane patching promotes healing and inhibits proteinase activity on wound healing following acute corneal alkali burn. Exp Eye Res 2000; 70: 329-37 .
108. Chacko DM, Das AV, Zhao X, James J, Bhattacharya S, Ahmad I. Transplantation of ocular stem cells: the role of injury in incorporation and differentiation of grafted cells in the retina. Vision Res 2003; 43: 937-46 .
109. Hao Y, Ma DH, Hwang DG, Kim WS, Zhang F. Identification of antiangiogenic and antiinflammatory proteins in human amniotic membrane. Cornea 2000; 19: 348-52 .
110. Kjaergaard N, Hein M, Hyttel L, et al. Antibacterial properties of human amnion and chorion in vitro. Eur J Obstet Gynecol Reprod Biol 2001; 94: 224-9 .
111. Kjaergaard N, Helmig RB, Schonheyder HC, Uldbjerg N, Hansen ES, Madsen H. Chorioamniotic membranes constitute a competent barrier to group B streptococcus in vitro. Eur J Obstet gynecol Reprod Biol 1999; 83: 165-9 .
112. Galask RP, Snyder IS. Antimicrobial factors in amniotic fluid. Am J Obstet Gynecol 1970; 106: 59-65 .
113. Shimmura S, Shimazaki J, Ohashi Y, Tsubota K. Antiinflammatory effects of amniotic membrane transplantation in ocular surface disorders. Cornea 2001; 20: 408-13 .
114. Meller D, Pires RT, Tseng SC. Ex vivo preservation and expansion of human limbal epithelial stem cells on amniotic membrane cultures. Br J Ophthalmol 2002; 86: 463-71 .
115. Brown SI, Bloomfield SE, Pearce DB. A follow-up report on transplantation of the alkaliburned cornea. Am J Ophthalmol 1974; 77: 538-42 .
116. Kremer I, Rajpal RK, Rapuano CJ, Cohen EJ, Laibson PR. Results of penetrating keratoplasty in aniridia. Am J Ophthalmol 1993; 115: 317-20 .
117. Tugal-Tutkun I, Akova YA, Foster CS. Penetrating keratoplasty in cicatrizing conjunctival diseases. Ophthalmology 1995; 102: 576-85 .
118. Holland EJ. Epithelial transplantation for the management of severe ocular surface disease. Trans Am Ophthalmol Soc 1996; 94: 677-743.
119. Holland EJ, Schwartz GS. The evolution of epithelial transplantation for severe ocular surface disease and a proposed classification system. Cornea 1996; 15: 549-56 .
120. Holland EJ, Schwartz GS. The Paton lecture: ocular surface transplantation: 10 years experience. Cornea 2004; 23: 425-31 .
121. Dua HS, Azuara-Blanco A. Autologous limbal transplantation in patients with unilateral corneal stem cell deficiency. Br J Ophthalmol 2000; 84: 273-8 .
122. Yao YF, Zhang B, Zhou P, Jiang JK. Autologous limbal grafting combined with deep lamellar keratoplasty in unilateral eye with severe chemical or thermal burn at late stage. Ophthalmology 2002; 109: 2011-7 .
123. Rao SK, Rajagopal R, Sitalakshmi G, Padmanabhan P. Limbal allografting from related live donors for corneal surface reconstruction. Ophthalmology 1999; 106: 822-8 .
124. Daya SM, Ilari FA. Living related conjunctival limbal allograft for the treatment of stem cell deficiency. Ophthalmology 2001; 108: 126-33; discussion 133-4 .
125. Tsubota K, Satake Y, Kaido M, et al. Treatment of severe ocular-surface disorders with corneal epithelial stem-cell transplantation. N Engl J Med 1999; 340: 1697-703 .
126. Dua HS, Azuara-Blanco A. Allo-limbal transplantation in patients with limbal stem cell deficiency. Br J Ophthalmol 1999; 83: 414-9 .
127. Holland EJ, Djalilian AR, Schwartz GS. Management of aniridic keratopathy with keratolimbal allograft: a limbal stem cell transplantation technique. Ophthalmology 2003; 110: 125-30 .
128. Solomon A, Ellies P, Anderson DF, et al. Long-Term outcome of keratolimbal allograft with or without penetrating keratoplasty for total limbal stem cell deficiency. Ophthalmology 2002; 109: 1159-66 .
129. Jenkins C, Tuft S, Liu C, Buckley R. Limbal transplantation in the management of chronic contact-lens-Associated epitheliopathy. Eye 1993; 7 (Pt 5): 629-33 .
130. Sloper CM, Powell RJ, Dua HS. Tacrolimus (FK506) in the management of high-risk corneal and limbal grafts. Ophthalmology 2001; 108: 1838-44 .
131. Pellegrini G, Traverso CE, Franzi AT, Zingirian M, Cancedda R, De Luca M. Long-Term restoration of damaged corneal surfaces with autologous cultivated corneal epithelium. Lancet 1997; 349: 990-3 .
132. Schwab IR, Reyes M, Isseroff RR. Successful transplantation of bioengineered tissue replacements in patients with ocular surface disease. Cornea 2000; 19: 421-6 .
133. Tsai RJ, Li LM, Chen JK. Reconstruction of damaged corneas by transplantation of autologous limbal epithelial cells. N Engl J Med 2000; 343: 86-93 .
134. Koizumi N, Inatomi T, Suzuki T, Sotozono C, Kinoshita S. Cultivated corneal epithelial stem cell transplantation in ocular surface disorders. Ophthalmology 2001; 108: 1569-74 .
135. Daya SM, Watson A, Sharpe JR, et al. Outcomes and DNA analysis of ex vivo expanded stem cell allograft for ocular surface reconstruction. Ophthalmology 2005; 112: 470-7 .
136. Shimazaki J, Aiba M, Goto E, Kato N, Shimmura S, Tsubota K. Transplantation of human limbal epithelium cultivated on amniotic membrane for the treatment of severe ocular surface disorders. Ophthalmology 2002; 109: 1285-90 .
137. Nakamura T, Koizumi N, Tsuzuki M, et al. Successful regrafting of cultivated corneal epithelium using amniotic membrane as a carrier in severe ocular surface disease. Cornea 2003; 22: 70-1 .
138. Joseph A, Powell-Richards AO, Shanmuganathan VA, Dua HS. Epithelial cell characteristics of cultured human limbal explants. Br J Ophthalmol 2004; 88: 393-8 .
139. Koizumi N, Cooper LJ, Fullwood NJ, et al. An evaluation of cultivated corneal limbal epithelial cells, using cell-suspension culture. Invest Ophthalmol Vis Sci 2002; 43: 2114-21 .
140. Nakagawa S, Nishida T, Kodama Y, Itoi M. Spreading of cultured corneal epithelial cells on fibronectin and other extracellular matrices. Cornea 1990; 9: 125-30 .
141. Nishida K, Yamato M, Hayashida Y, et al. Functional bioengineered corneal epithelial sheet grafts from corneal stem cells expanded ex vivo on a temperature-responsive cell culture surface. Transplantation 2004; 77: 379-85 .
142. Schwab IR. Cultured corneal epithelia for ocular surface disease. Trans Am Ophthalmol Soc 1999; 97: 891-986.
143. Wang DY, Hsueh YJ, Yang VC, Chen JK. Propagation and phenotypic preservation of rabbit limbal epithelial cells on amniotic membrane. Invest Ophthalmol Vis Sci 2003; 44: 4698-704 .
144. Sangwan VS, Vemuganti GK, Singh S, Balasubramanian D. Successful reconstruction of damaged ocular outer surface in humans using limbal and conjuctival stem cell culture methods. Biosci Rep 2003; 23: 169-74 .
145. Tseng SC, Meller D, Anderson DF, et al. Ex vivo preservation and expansion of human limbal epithelial stem cells on amniotic membrane for treating corneal diseases with total limbal stem cell deficiency. Adv Exp Med Biol 2002; 506: 1323-34 .
146. Lindberg K, Brown ME, Chaves HV, Kenyon KR, Rheinwald JG. In vitro propagation of human ocular surface epithelial cells for transplantation. Invest Ophthalmol Vis Sci 1993; 34: 2672-9 .
147. Koizumi N, Rigby H, Fullwood NJ, et al. Comparison of intact and denuded amniotic membrane as a substrate for cell-suspension culture of human limbal epithelial cells. Graefes Arch Clin Exp Ophthalmol 2007; 245: 123-34 .
148. Sangwan VS, Matalia HP, Vemuganti GK, et al. Clinical outcome of autologous cultivated limbal epithelium transplantation. Indian J Ophthalmol 2006; 54: 29-34 .
149. Nakamura T, Inatomi T, Sotozono C, et al. Transplantation of autologous serum-derived cultivated corneal epithelial equivalents for the treatment of severe ocular surface disease. Ophthalmology 2006; 113: 1765-72 .
150. Shortt AJ, Secker GA, Notara MD, et al. Transplantation of ex vivo cultured limbal epithelial stem cells: a review of techniques and clinical results. Surv Ophthalmol 2007; 52: 483-502 .
151. Nakamura T, Endo K, Cooper LJ, et al. The successful culture and autologous transplantation of rabbit oral mucosal epithelial cells on amniotic membrane. Invest Ophthalmol Vis Sci 2003; 44: 106-16 .
152. Nakamura T, Inatomi T, Sotozono C, Amemiya T, Kanamura N, Kinoshita S. Transplantation of cultivated autologous oral mucosal epithelial cells in patients with severe ocular surface disorders. Br J Ophthalmol 2004; 88: 1280-4 .
153. Inatomi T, Nakamura T, Koizumi N, Sotozono C, Yokoi N, Kinoshita S. Midterm results on ocular surface reconstruction using cultivated autologous oral mucosal epithelial transplantation. Am J Ophthalmol 2006; 141: 267-75 .
154. Caplan AI. Mesenchymal stem cells. J Orthop Res 1991; 9: 641-50 .
155. Owen M. Lineage of osteogenic cells and their relationship to the stromal system. Excerpta Med 1985; 3: 340-8.
156. Prockop DJ. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 1997; 276: 71-4 .
157. Yamanaka S, Li J, Kania G, et al. Pluripotency of embryonic stem cells. Cell Tissue Res 2008; 331: 5-22 .
158. Lensch MW, Daheron L, Schlaeger TM. Pluripotent stem cells and their niches. Stem Cell Rev 2006; 2: 185-201 .
159. Dawson E, Mapili G, Erickson K, et al. Biomaterials for stem cell differentiation. Adv Drug Deliv Rev 2007; 273: 320-9 .
160. Atala A. Engineering tissues, organs and cells. J Tissue Eng Regen Med 2007; 1: 83-96 .
161. Kim SS, Vacanti JP. The current status of tissue engineering as potential therapy. Semin Pediatr Surg 1999; 8: 119-23 .
162. Dazzi F, Horwood NJ. Potential of mesenchymal stem cell therapy. Curr Opin Oncol 2007; 19: 650-5 .
163. Langer RS, Vacanti JP. Tissue engineering: the challenges ahead. Sci Am 1999; 280: 86-9 .
164. Langer R, Vacanti JP. Tissue engineering. Science 1993; 260: 920-6 .
165. Vandenburgh H, DelTatto M, Shansky J, et al. Tissue-engineered skeletal muscle organoids for reversible gene therapy. Hum Gene Ther 1996; 7: 2195-9 .
166. Petite H, Viateau V, Bensaid W, et al. Tissue-engineered bone regeneration. Nat Biotechnol 2000; 18: 959-65 .
167. Peretti GM, Randolph MA, Villa MT, et al. Cell-based tissue-engineered allogeneic implant for cartilage repair. Tissue Eng 2000; 6: 567-73 .
168. Woerly S, Plant GW, Harvey AR. Neural tissue engineering from polymer to biohybrid organs. Biomaterials 1996; 17: 301-10 .
169. Ishaug SL, Crane GM, Miller MJ, Yasko AW, Yaszmski MJ, Mikos A G. Bone formation by three dimensional stromal osteoblast culture in biodegradable polymer scaffold. J Biomed Mater Res 1997; 36: 17-28 .
170. Freed LE, Vunjak-Novakovic G. Culture of organized cell communities. Adv Drug Deliv Rev 1998; 33: 15-30 .
171. Freed LE, Vunjak-Novakovic G, Langer R. Cultivation of cell-polymer cartilage implants in bioreactors. J Cell Biochem 1993; 51: 257-64 .
172. Niklason LE, Gao J, Abbott WM, et al. Functional arteries grow in vivo. Science 1999; 284: 489-93 .
173. Ma PX, Langer R. Morphology and mechanical function of long-Term in vitro engineered cartilage. J Biomed Mater Res 1999; 44: 217-21 .
174. Schneider AI, Maier-Reif K, Graeve T. Constructing an in vitro cornea from cultures of the three specific corneal cell types. In Vitro Cell Dev Biol Anim 1999; 35: 515-26 .
175. Papas KK, Long RC, Sambanis A, Constantinidis I. Development of a bioartificial pancreas: I. Long-Term propagation and basal and induced secretion from entrapped TC3 cell cultures. Biotechnol Bioeng 1999; 66: 219-30 .
176. Griffith M, Osborne R, Munger R, et al. Functional human corneal equivalents constructed from cell lines. Science 1999; 286: 69-72 .
177. Kloth S, Ebenbeck C, Kubitza M. Stimulation of renal microvascular development under organotypic culture conditions. FASEB J 1995; 9: 963-7 .
178. Pankajakshan D, Krishnan VK, Krishnan LK. Vascular tissue generation in response to signaling molecules integrated with a novel poly(epsilon- caprolactone)-fibrin hybrid scaffold. J Tissue Eng Regen Med 2007; 1: 389-97 .
179. Colton CK. Implantable biohybrid artificial organs. Cell Transplant 1995; 4: 415-36 .
180. Polverini PJ. The pathophysiology of angiogenesis. Crit Rev Oral Biol Med 1995; 6: 230-47 .
181. Downs EC, Robertson NE, Riss TL, Plunkett ML. Calcium alginate beads as a slow release system for delivering angiogenic molecules in vivo and in vitro. J Cell Physiol 1992; 152: 422-9 .
182. Iwakura A, Tabata Y, Tamura N, et al. Gelatin sheets incorporating basic fibroblast growth factor enhances healing of devascularized sternum in diabetic rats. Circulation 2001; 104: 1325-9 .
183. Edelman ER, Mathiowitz E, Langer R, Klagsburn M. Controlled and modulated release of basic fibroblast growth factor. Biomaterials 1991; 12: 619-26.
184. Ware JA, Simons M. Angiogenesis in ischemic heart disease. Nat Med 1997; 3: 158-64 .
185. Thompson JA, Anderson KD, Dipietro JM, et al. Site-directed neovessel formation in vivo. Science 1988; 241: 1349-52 .
186. Tabata Y, Nagano A, Ikada Y. Biodegradation of hydrogel carrier incorporating fibroblast growth factor. Tissue Eng 1999; 5: 127-38 .
187. Tabata Y, Ikada Y. Vascularization effect of basic fibroblast growth factor released from gelatin hydrogels with different biodegradabilities. Biomaterials 1999; 20: 2169-75 .
188. Cai S, Liu Y, Shu XZ, Prestwich GD. Injectable glycosaminoglycan hydrogels for controlled release of human basic fibroblast growth factor. Biomaterials 2005; 26: 6054-67 .
189. Dogan AK, Gumusderelioglu M, Aksoz E. Controlled release of EGF and bFGF from dextran hydrogels in vitro and in vivo. J Biomed Mater Res B Appl Biomater 2005; 74: 504-10 .
190. Tabata Y, Ikada Y. Protein release from gelatin matrices. Adv Drug Deliv Rev 1998; 31: 287-301 .
191. Nakamura T, Nishikawa T, Hagiya M, et al. Molecular cloning and expression of human hepatocyte growth factor. Nature 1989; 342: 440-3 .
192. Rubin RS, Chan AM, Bottaro DP, et al. A broad-spectrum human lung fibroblast-derived mitogen is a variant of hepatocyte growth factor. Proc Natl Acad Sci U S A 1991; 88: 415-9 .
193. Weidner KM, Arakaki N, Vandekerckhove J, et al. Evidence for the identity of human scatter factor and human hepatocyte growth factor. Proc Natl Acad Sci U S A 1991; 88: 7001-5 .
194. Montesano R, Matsumoto K, Nakamura T, Orci L. Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor. Cell 1991; 67: 901-8 .
195. Miyamoto S, Takaoka K, Okada T, et al. Evaluation of polylactic acid
196. Gombotz WR, Pankey SC, Bouchard LS, Ranchalis J, Puolakkainen P. Controlled release of TGF-beta 1 from a biodegradable matrix for bone regeneration. J Biomater Sci Polym Ed 1993; 5: 49-63 .
197. Su Y, Cui Z, Li Z, Block ER. Calpain-2 regulation of VEGF-mediated angiogenesis FASEB J 2006; 20: 1443-51 .
198. Ueda H, Hong L, Yamamoto M, et al. Use of collagen sponge incorporating transforming growth factor-beta1 to promote bone repair in skull defects in rabbits. Biomaterials 2002; 23: 1003-9 .
199. Nagai H, Tsukuda R, Mayahara H. Effects of basic fibroblast growth factor (bFGF) on bone formation in growing rats. Bone 1995; 16: 367-74 .
200. Wang EA, Rosen V, DAlessandro JS, et al. Recombinant human bone morphogenetic protein induces bone formation. Proc Natl Acad Sci U S A 1990; 87: 2220-7 .
201. Minuth WW, Sittinger M, Kloth S. Tissue engineering: generation of differentiated artificial tissues for biomedical applications. Cell Tissue Res 1998; 291: 1-11 .
202. Ingber DE, Prusty D, Sun Z, Betensky H, Wang N. Cell shape, cytoskeletal mechanics, and cell cycle control in angiogenesis. J Biomech 1995; 28: 1471-84 .
203. Xie Y, Yang ST, Kniss DA. Three-dimensional cell-scaffold constructs promote efficient gene transfection: implications for cell-based gene therapy. Tissue Eng 2001; 7: 585-98 .
204. Yoshikawa T, Ohgushi H, Akahane M, et al. Analysis of gene expression in osteogenic cultured marrow/hydroxyapatite construct implanted at ectopic sites: a comparison with the osteogenic ability of cancellous bone. J Biomed Mater Res 1998; 41: 568-73 .
205. Noshi T, Yoshikawa T, Ikeuchi M, et al. Enhancement of the in vivo osteogenic potential of marrow/hydroxyapatite composites by bovine bone morphogenetic protein. J Biomed Mater Res 2000; 52: 621-30 .
206. Goldstein AS, Juarez TM, Helmke CD, Gustin MS, Mikos AG. Effect of convection on osteoblastic cell growth and function in biodegradable polymer foam scaffolds. Biomaterials 2001; 22: 1279-88 .
207. Ma T, Li Y, Yang ST, Kniss DA. Effects of pore size in 3-D fibrous matrix on human trophoblast tissue development. Biotechnol Bioeng 2000; 70: 606-18 .
208. Mueller-Klieser W. Three-dimensional cell cultures: from molecular mechanisms to clinical applications. Am J Physiol 1997; 273: C1109-23.
209. Thomson RC, Wake MC, Yaszemski MJ, Mikos AG. Biodegradable polymer scaffolds to regenerate organs. Adv Polym Sci (Biopolymers II) 1995; 122: 245-73 .
210. Chen G, Ushida T, Tateishi T. Development of biodegradable porous scaffolds for tissue engineering. Mater Sci Eng C 2001; 17: 63-9 .
211. Chen G, Ushida T, Tateishi T. Preparation of poly( l -lactic acid) and poly( dl -lactic-co-glycolic acid) foams by use of ice microparticules. Biomaterials 2001; 22: 2563-7 .
212. Wintermantel E, Mayer J, Blum J, Eckert KL, Lscher P, Mathey M. Tissue engineering scaffolds using superstructures. Biomaterials 1996; 17: 83-91 .
213. Zhao K, Deng Y, Chen JC, Chen GQ. Polyhydroxyalkanoate (PHA) scaffolds with good mechanical properties and biocompatibility. Biomaterials 2003; 24: 1041-5 .
214. Hutmatcher DW. Scaffolds in tissue engineering bone and cartilage. Biomaterials 2000; 21: 2529-43 .
215. Whang K, Thomas CH, Healy KE, Nuber G. A novel method to fabricate bioabsorbable scaffolds. Polymer 1995; 36: 837-42 .
216. Taboas JM, Maddox RD, Krebsbach PH, Hollister SJ. Indirect solid free form fabrication of local and global porous, biomimetic and composite 3D polymer-ceramic scaffolds. Biomaterials 2003; 24: 181-94 .
217. Gomes ME, Ribeiro AS, Malafaya PB, Reis RL, Cunha AM. A new approach based on injection moulding to produce biodegradable starch-based polymeric scaffolds: morphology, mechanical and degradation behaviour. Biomaterials 2001; 22: 883-9 .
218. Hutmatcher DW, Schantz T, Zein I, Ng KW, Teoh SH, Tan KC. Mechanical properties and cell cultural response of polycaprolactone scaffolds designed and fabricated via fused deposition modeling. Mechanical properties and cell cultural response. J Biomed Mater Res 2001; 5: 203-16 .
219. Hosseinkhani H, Hosseinkhani M, Tian F, Kobayashi H, Tabata Y. Bone regeneration on a collagen sponge-self assembled peptide-Amphiphile nanofibers hybrid scaffold. Tissue Eng 2007; 13: 1-9 .
220. Weadock K, Olson RM, Silver FH. Evaluation of collagen crosslinking techniques. Biomater Med Devices Artif Organs 1983; 11: 293-318 .
221. Cai Z, Cheng G. Novel method to produce poly (3-hydroxybutyrate) scaffolds with controlled multi-pore size. J Mater Sci Lett 2003; 22: 153-5 .
222. Cai Q, Yang J, Bei J, Wang S. A novel porous cells scaffold made of polylatic-dextran blend by combining phase-separation and particle-leaching techniques. Biomaterials 2002; 23: 4483-92 .
223. Zein I, Hutmacher DW, Tan KC, Teoh SH. Fused deposition modeling of novel architectures for tissue applications. Biomaterials 2002; 23: 1169-85 .
224. Lin ASP, Borrows TH, Cartmell SH, Guldberg RE. Microarchitectural and mechanical characterization of oriented porous polymer scaffolds. Biomaterials 2003; 24: 481-9 .
225. Oxley HR, Corkhill PH, Fitton JH, Tighe BJ. Macroporous hydrogels for biomedical applications: methodology and morphology. Biomaterials 1993; 14: 1064-72 .
226. Chirila TV, Constable IJ, Crawford GJ, et al. Poly(2-hydroxyethyl methacrylate) sponges as implant materials: in vivo and in vitro evaluation. Biomaterials 1993; 14: 26-38 .
227. Zhang X, Jiang XN, Sun C. Micro-stereolithography of polymeric and ceramic microstructures. S ens Actuators A 1 997; 7 7: 1 49- 5 6.
228. Kane RS, Takayama S, Ostuni E, Ingber DE, Whitesides GM. Patterning proteins and cells using soft lithography. Biomaterials 1999; 20: 2363-76 .
229. Mikos AG, Sakarinos G, Vacanti JP, Langer RS, Cima LG. Biocompatible polymer membranes and methods of preparation of three dimensional membrane structures. Patent number 5514378, issue date May 7, 1996.
230. Hutmacher DW, Ng KW, Kaps C, Sittinger M, Klaring S. Elastic cartilage engineering using novel scaffold architectures in combination with a biomimetic cell carrier. Biomaterials 2003; 24: 4445-58 .
231. Blacher S, Maquet V, Schils F, et al. Image analysis of the axonal ingrowth into poly( d, l-lactide) porous scaffolds in relation to the 3-D porous structure, Biomaterials 2003; 24: 1033-40 .
232. Nikpour M, Chaouk H, Mau A, et al. Porous conducting membranes based on polypyrrole- PMMA composites. Synth Met 1999; 99: 121-6.
233. Cavallini A, Notarnicola M, Berloco P, Lippolis A, De Leo A. Use of macroporous polypropylene filter to allow identification of bacteria by PCR in human fecal simples. J Microbiol Methods 2000; 39: 265-70 .
234. Pastist CM, Mulder MB, Gautier SE, Maquet V, Jerome R, Oudega M. Freeze-dried poly ( d, llactic acid) macroporous guidance scaffolds impregnated with brain-derived neurotrophic factor in the transected adult rat thoracic spinal cord. Biomaterials 2004; 25: 1569-82 .
235. Schmidt CE, Leach JB. Neural tissue engineering: strategies for repair and regeneration. Annu Rev Biomed Eng 2003; 5: 293-347 .
236. Kang HW, Tabata Y, Ikada Y. Fabrication of porous gelatine scaffolds for tissue engineering. Biomaterials 1999; 20: 1339-44 .
237. Plant GW, Harvey AR, Chirila TV, et al. Axonal growth within poly (2-hydroxyethyl methacrylate) sponges infiltrated with Schwann cells and implanted into the lesioned rat optic tract. Brain Res 1995; 671: 119-30 .
238. Shugens CH, Maquet V, Grandfils C, et al. Biodegradable and macroporous polylactide implants for cell transplantation: 1. Preparation of macroporous polylactide supports by solid-liquid phase separation. Polymer 1996; 37: 1027-38 .
239. Maquet V, Martin D, Scholtes F, et al. Poly( d, l -lactide) foams modified by poly(ethylene oxide)-block-poly( d, l -lactide) copolymers and a-FGF: in vitro and in vivo evaluation for spinal cord regeneration. Biomaterials 2001; 22: 1137-46 .
240. Ma Z, Kotaki M, Inai R, Ramakrishna S. Potential of nanofiber matrix as tissue-engineering scaffolds. Tissue Eng 2005; 11: 101-9 .
241. Rosenberg MD. Cell guidance by alterations in monomolecular films. Science 1963; 139: 411-2 .
242. Webster TJ, Siegel RW, Bizios R. Osteoblast adhesion on nanophase ceramics. Biomaterials 1999; 20: 1221-7 .
243. Pricea RL, Waidb MC, Haberstroha KM, et al. Selective bone cell adhesion on formulations containing carbon nanofibers. Biomaterials 2003; 24: 1877-87 .
244. Elias KL, Price RL, Webster TJ. Enhanced functions of osteoblasts on nanometer diameter carbon fibers. Biomaterials 2002; 23: 3279-87 .
245. Webster TJ, Schalder LS, Siegel RW, et al. Mechanisms of enhanced osteoblast adhesion on nanophase alumina involve vitronectin. Tissue Eng 2001; 7: 291-301 .
246. Smith LA, Ma PX. Nano-fibrous scaffolds for tissue engineering. Colloids Surf B Biointerfaces 2004; 10: 125-31 .
247. Kameoka J, Verbridge SS, Liu H, et al. Fabrication of suspended silica glass nanofibers from polymeric materials using a scanned electrospinning source. Nano Lett 2004; 4: 2105-8 .
248. Tian F, Hosseinkhani H, Hosseinkhani M, et al. Quantitative analysis of cell adhesion on aligned micro- and nanofibers. J Biomed Mater Res A 2008; 84: 291-9 .
249. Hartgerink JD, Beniash E, Stupp SI. Self-Assembly and mineralization of peptide-Amphiphile nanofibers. Science 2001; 294: 1684-8 .
250. Hong Y, Legge RL, Zhang S, Chen P. Effect of amino acid sequence and pH on nanofiber formation of self-Assembling peptides EAK16-II and EAK16-IV. Biomacromolecules 2003; 4: 1433-42 .
251. Ruoslahti E, Pierschbacher MD. New perspectives in cell adhesion: RGD and integrins. Science 1987; 238: 491-7 .
252. Williams JA. Disintegrins: RGD-containing proteins which inhibit cell/matrix interactions (adhesion) and cell/cell interactions (aggregation) via the integrin receptors. Pathol Biol 1992; 40: 813-21 .
253. Evans ND, Gentleman E, Polak JM. Scaffolds for stem cells. Materials Today 2006; 12: 26-33 .
254. Silva GA, Czeisler C, Niece KL, et al. Selective differentiation of neural progenitor cells by high-epitope density nanofibers. Science 2004; 303: 1352-5 .
255. Hosseinkhani H, Hosseinkhani M, Tian F, Kobayashi H, Tabata Y. Osteogenic differentiation of mesenchymal stem cells in self-Assembled. Biomaterials 2006; 27: 4079-86 .
256. Hosseinkhani H, Hosseinkhani M, Tian F, et al. Enhanced angiogenesis through controlled release of basic fibroblast growth factor from peptide amphiphile for tissue regeneration. Biomaterials 2006; 27: 5836-44